TRLV Slides As Traders Test Support After Sharp Intraday Reversal

Trulieve Cannabis Corp. Subordinate stocks have been trading down by -10.82 percent amid heightened regulatory and legalization uncertainty.

Weekly Update Jun 08 – Jun 12, 2026: On Sunday, June 14, 2026 Trulieve Cannabis Corp. Subordinate stock [NYSE: TRLV] is trending down by -10.82%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – positive

TRLV occupies a mid-cap position in healthcare services with solid top-line scale (~$1.18B revenue) and strong gross (59.7%) and EBITDA (28.2%) margins, but inconsistent profitability (pretax margin -0.5%, net -7%) and negative ROE/ROA highlight restructuring and amortization drag. Balance sheet quality is a strength: current ratio 5.3, net leverage moderate (total debt/equity 0.54, interest coverage 5.5). Free cash flow of $55.7M in Q1 and price-to-free-cash ~8x indicate the equity is fundamentally underappreciated versus cash generation.

Technically, TRLV is in a short-term corrective phase after failing to hold above the 12.00 area. The weekly sequence from 11.70 → 11.366 → 10.30 reflects accelerating downside with lower highs and lower lows, confirming a near-term downtrend. Intraday 5-minute candles show heavy volume on breaks below 11.50 and again under 10.80, followed by stabilizing but lighter volume near 10.20–10.30. The first actionable level is 10.00: a decisive close below suggests continuation toward 9.25, while sustained reclaim of 11.00 would signal downside exhaustion.

With no fresh company-specific news, TRLV trades primarily on fundamentals and sector sentiment. Versus healthcare and pharma benchmarks, it offers superior balance sheet liquidity and cash conversion but lags on reported earnings quality and ROE, justifying a discount multiple but not current levels. I expect a 6–12 month re-rating toward 1.8–2.0x sales and 10–11x FCF, implying a price range of 13–15. Key support sits at 10.00, major resistance at 12.50.

More Breaking News

• ACHR Stock Advances As Archer Aviation Pushes Toward FAA Finish Line
• ACVA Stock Slides As Barrington Slashes Rating, Sets $7 Target
• DSY Surges Then Fades As Traders Hunt New Levels
• SFIX Jumps After UBS Hike Signals Cautious Repricing

Quick Financial Overview

TRLV’s weekly chart shows a clear loss of momentum. Price moved from an early high near 12.29 down to a recent close around 10.3, which is more than a $2 pullback from the top of this short data window. The fact that each week has made lower closes signals that sellers are in control for now, and short-term trend traders will treat bounces carefully until a higher low forms.

On the intraday read, Trulieve Cannabis Corp. Subordinate opened in the mid-11s and quickly sold off toward 10.10 before stabilizing near 10.35. That kind of wide intraday range, from the 11.70 area down to just over 10, usually reflects either profit taking after a prior run or a shift in sentiment. For day traders, that volatility offers opportunity, but it also raises risk if entries are late or stops are too tight.

Fundamentally, TRLV shows a mixed picture. Revenue runs around $1.18B with a strong 59.7% gross margin, yet net margin sits near -7%, and return on equity is firmly negative. On the positive side, the company’s current ratio above 5 and quick ratio around 3 indicate solid liquidity, while debt-to-equity near 0.54 suggests leverage is present but not extreme. Strong free cash flow and a price-to-sales near 1.56 place Trulieve Cannabis Corp. Subordinate in a value zone if it can push margins back to positive territory.

Conclusion

TRLV: Trading Outlook And Risk Map

For active traders, TRLV is sitting in that uncomfortable but often profitable zone where price is weak, but the balance sheet is not. The slide from 12+ down toward 10 shows clear selling pressure, yet Trulieve Cannabis Corp. Subordinate still carries strong gross margins and healthy cash levels. That combination sets up a tug of war between fundamental support and current bearish momentum.

Key levels now sit near the recent low around 10 and the prior resistance area in the low 12s. Sustained trading below 10 would confirm that sellers remain dominant and could invite more short-term downside. A reclaim of 11.50–12 with rising volume, on the other hand, would be the first real sign that TRLV is ready to build a base and trap late shorts.

Risk management is everything here. The negative net margins and weak return metrics tell you the business still has work to do, even with solid liquidity behind it. As I often tell my students as a trading expert, “Your edge in names like Trulieve Cannabis Corp. Subordinate doesn’t come from guessing the turnaround — it comes from defining your levels, sizing small, and letting the chart prove the shift before you commit bigger.” That mindset lines up with a broader philosophy many disciplined traders share. As millionaire penny stock trader and teacher Tim Sykes, says, “Preparation plus patience leads to big profits.” This article is for educational and research use only.
“,”scores”:{“risk-level”:”medium”},”trade”:”true

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks